Steven M. Johnson

Biochemical and Structural Evaluation of Highly Selective 2-Arylbenzoxazole-Based Transthyretin Amyloidogenesis Inhibitors

Steven M. Johnson, Stephen Connelly, Ian A. Wilson et al. · Journal of Medicinal Chemistry · 2007 · 134 citations · Full text

Molecular Docking, High Binding Selectivity, Medicinal Chemistry +14

Antibacterial agents that inhibit two-component signal transduction systems

John F. Barrett, Raúl Goldschmidt, Laura Lawrence et al. · Proceedings of the National Academy of Sciences · 1998 · 122 citations · Full text

Antibacterial Agents, Antimicrobial Chemotherapy, Bacterial Pathogens +22

Development of <i>Toxoplasma gondii</i> Calcium-Dependent Protein Kinase 1 (<i>Tg</i>CDPK1) Inhibitors with Potent Anti-<i>Toxoplasma</i> Activity

Steven M. Johnson, Ryan C. Murphy, Jennifer A. Geiger et al. · Journal of Medicinal Chemistry · 2012 · 113 citations · Full text

Signal Transduction, Parasitic Protozoa, Medicine +12

Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril Formation

Steven M. Johnson, H. Michael Petrassi, S.K. Palaninathan et al. · Journal of Medicinal Chemistry · 2005 · 103 citations

Medicinal Chemistry, Several Bisaryloxime Ethers, Biochemistry +12

Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors

Kayode K. Ojo, Claudia Pfander, Natascha Mueller et al. · Journal of Clinical Investigation · 2012 · 98 citations · Full text

Transmission-blocking Compounds, African Trypanosomiasis, Asexual Stage +13